This report identifies the global glycobiology/glycomics market size in for the year 2015-2017, and forecast of the same for year 2022. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global glycobiology/glycomics market.
Geographically North America dominated the global glycobiology/glycomics market owing to presence of global bio tech companies and pharmaceutical players and higher investment into R& activities in the region. North America was followed by Europe and Asia-Pacific as the second and third largest markets for glycobiology/glycomics. However Asia-Pacific is expected to remain the fastest growing market during the period of study driven by economic developments, increasing presence of bio tech companies and growing government funding to support new product developments are the key factors driving the growth of market in developing regions.
This report segments global glycobiology/glycomics market on the basis of product, end users, applications, end user and regional market as follows:
On the basis of product this report on global glycobiology/glycomics market is segmented as follows, covering all major products in the glycobiology/glycomics as follows: KITS, Reagents, Instruments and enzymes
This report on global glycobiology/glycomics also covers in detail various applications of glycobiology/glycomics, some of the major applications covered in the report are Diagnostics, Drug Discovery & Development, Oncology, Immunology, and Other Applications
This report on global glycobiology/glycomics also covers in detail various end users of glycobiology/glycomics, some of the major end users covered in the report are Academic Research Institutes, Pharmaceutical & Biotechnology Companies and Contract Research Organizations
This report on glycobiology/glycomics has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets in each of the region
Sample companies profiled in this report are:
New England Biolabs Inc.
Agilent Technologies, Inc.
2. Executive Summary
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Glycobiology/Glycomics Market– Market Forces
4.1.1. Growing R&D activities and Increase in Funding for Proteomics
4.1.2. Technological advancement
4.2.1. High degree of consolidation amongst existing player
4.2.2. Stringent regulatory framework
4.3.1. Developing nations presents high growth opportunity
4.4.1. High cost of instruments and its maintenance
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Glycobiology/Glycomics Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life cycle Analysis
5.5. Suppliers & Distributors
6. Glycobiology/Glycomics Market, By Products
6.1.1. Glycan Labeling Kits
6.1.2. Glycan Purification Kits
6.1.3. Glycan Release Kits
6.1.4. Other Glycomics Kits
6.2.4. Other Reagents
6.3.5. Other Glycomics Enzymes
6.4.1. Antibody Arrays
6.4.3. Lectin Arrays
6.4.5. Mass Spectrometers
6.4.6. Other Glycomics Instruments
7. Glycobiology/Glycomics Market, By Application
7.2. Drug Discovery & Development
7.5. Other Applications
8. Glycobiology/Glycomics Market, By End User
8.1. Academic Research Institutes
8.2. Pharmaceutical & Biotechnology Companies
8.3. Contract Research Organizations
9. Glycobiology/Glycomics Market, By Geography
9.1.7. Rest of Europe
9.2. Asia Pacific
9.2.4. South Korea
9.2.5. Rest of Asia-Pacific
9.3. North America
9.4. Rest of the World (RoW)
9.4.1. Middle East
9.4.2. South America
10. Glycobiology/Glycomics – Market Entropy
10.2. Technological Developments
10.3. Merger & Acquisitions, and Joint Ventures
10.4. Supply- Contract
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
11.1. Merck KGaA
11.2. Takara Bio, Inc.
11.3. Shimadzu Corporation
11.4. Bruker Corporation
11.5. Waters Corporation
11.6. New England Biolabs Inc.
11.7. Agilent Technologies, Inc.
11.8. Danaher Corporation
11.9. ProZyme, Inc.
11.10. Thermo Fisher Scientific, Inc.
*More than 30 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12.3. Research Methodology
12.5. Compilation of Expert Insights
- Merck KGaA
- Takara Bio, Inc.
- Shimadzu Corporation
- Bruker Corporation
- Waters Corporation
- New England Biolabs Inc.
- Agilent Technologies, Inc.
- Danaher Corporation
- ProZyme, Inc.
- Thermo Fisher Scientific, Inc.